Tsvetomir Yordanov
Tamara Vasojevic
Vishal Gupta
Dusan Cvetanovic
Strengthening Oncology Treatment Access in the Western Balkans
Weโre excited to announce that ๐๐ฟ๐ผ๐ป๐๐ถ๐ฒ๐ป๐ ๐ฐ๐ฌ๐ฌ๐บ๐ด (๐๐ก๐ก: ๐ฃ๐ฎ๐๐ผ๐ฝ๐ฎ๐ป๐ถ๐ฏ) is now available in Bosnia and Herzegovina, following its launch at the end of March. This marks one of the first generic launches of Pazopanib in the Western Balkans โ a step forward in expanding access to oncology treatments in the region. Pazopanib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor approved for the treatment of renal cell carcinoma and soft tissue sarcoma.
Leading The Way: Interview with Snezana Stojilkovic, Quality Director
In our secondย Leading the Way interview, Snezana Stojilkovic, Frontier Zdravljeโs Quality Director, shares insights from her 30-year journeyโfrom researcher to leading quality operations. She discusses the challenges of maintaining top-tier standards in a CDMO, the power of cross-team collaboration, and how our commitment to excellence drives success.
Leading The Way: Interview with Dusan Cvetanovic, Senior Site Director
As part of our new series, Leading The Way, we are proud to bring you exclusive insights from the leaders who are shaping the future of Frontier Zdravlje. In each interview, weโll dive into their unique perspectives, key experiences, and the strategies they employ to drive our company forward. Through these conversations, we aim to highlight the vision, innovation, and leadership that have defined Frontier Zdravlje for decades.
Frontier Zdravlje Achieves EcoVadis Certification: Top 35% for Global Sustainability
We are proud to announce that Frontier Zdravlje has been ๐ฐ๐ฒ๐ฟ๐๐ถ๐ณ๐ถ๐ฒ๐ฑ ๐ฏ๐ ๐๐ฐ๐ผ๐ฉ๐ฎ๐ฑ๐ถ๐, an independent ๐ด๐น๐ผ๐ฏ๐ฎ๐น ๐ฝ๐ฟ๐ผ๐๐ถ๐ฑ๐ฒ๐ฟ ๐ผ๐ณ ๐ฏ๐๐๐ถ๐ป๐ฒ๐๐ ๐๐๐๐๐ฎ๐ถ๐ป๐ฎ๐ฏ๐ถ๐น๐ถ๐๐ ๐ฟ๐ฎ๐๐ถ๐ป๐ด๐, placing us in the ๐๐ผ๐ฝ ๐ฏ๐ฑ% ๐ผ๐ณ ๐ฐ๐ผ๐บ๐ฝ๐ฎ๐ป๐ถ๐ฒ๐ assessed globally for sustainability!
Frontier Zdravlje Successfully Completes European Medicines Authority Inspection
Frontier Zdravlje recently completed a comprehensive six-day inspection by the European Medicines Authorityย fromย September 5-10, concluding successfully withย zero critical observations.
Frontier Zdravlje and BIO4 Campus: Shaping the Future of Biotech
The successful and long-term business of Frontier Zdravlje was also recognized by the Chamber of Commerce of Serbia (PKS). At the premises of the Regional Chamber of Commerce (RPK) in Leskovac, during the ceremonial session of the Parliament of Businessmen, Frontier Zdravlje was presented with the JUBILEE AWARD OF THE CHAMBER OF COMMERCE OF SERBIA for 70 years of successful business.